These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19912680)

  • 1. [Hot issues of immunology in viral hepatitis C].
    Zhao FT; Jia ZS
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):490-3. PubMed ID: 19912680
    [No Abstract]   [Full Text] [Related]  

  • 2. A target on the move: innate and adaptive immune escape strategies of hepatitis C virus.
    Thimme R; Lohmann V; Weber F
    Antiviral Res; 2006 Mar; 69(3):129-41. PubMed ID: 16413618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis C immunology].
    Alvarado Esquivel C; Leroux-Roels G
    Rev Invest Clin; 1999; 51(5):315-22. PubMed ID: 10614142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?
    Godkin A; Ng WF; Gallagher K; Betts G; Thomas HC; Lechler RI
    J Allergy Clin Immunol; 2008 May; 121(5):1277-1284.e3. PubMed ID: 18355912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunology of hepatitis B and hepatitis C virus infections.
    Boonstra A; Woltman AM; Janssen HL
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1049-61. PubMed ID: 19187866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
    Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
    Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
    El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
    J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
    Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C.
    Schupper H; Hayashi P; Scheffel J; Aceituno S; Paglieroni T; Holland PV; Zeldis JB
    Hepatology; 1993 Nov; 18(5):1055-60. PubMed ID: 7693570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T and B cells in hepatitis C virus control: what they do and when they fail.
    Ferrari C
    Gastroenterology; 2007 Feb; 132(2):801-5. PubMed ID: 17261303
    [No Abstract]   [Full Text] [Related]  

  • 11. [The establishment of antigen sandwiched ELISA for detection of total antibodies to hepatitis C virus].
    Hong S; Mao P; He H; Fu T; Liu H; Bai Y; Yang J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):375-7. PubMed ID: 15617253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prevalence of anti-hepatitis C virus antibodies in differing South American populations.
    Robinson JW; Rosas M; Guzman F; Patarroyo ME; Moreno A
    J Med Virol; 1996 Oct; 50(2):188-92. PubMed ID: 8915886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus.
    Puig M; Mihalik K; Tilton JC; Williams O; Merchlinsky M; Connors M; Feinstone SM; Major ME
    Hepatology; 2006 Sep; 44(3):736-45. PubMed ID: 16941702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of gene-electro transfer and adjuvant cytokines in increasing the potency of hepatitis C virus genetic vaccination.
    Arcuri M; Cappelletti M; Zampaglione I; Aurisicchio L; Nicosia A; Ciliberto G; Fattori E
    J Gene Med; 2008 Sep; 10(9):1048-54. PubMed ID: 18655231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors.
    Semmo N; Barnes E; Taylor C; Kurtz J; Harcourt G; Smith N; Klenerman P
    Lancet; 2005 Jan 22-28; 365(9456):327-9. PubMed ID: 15664228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P; López JA; Elola C; Domingo CJ; Echevarria JM
    Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology. NK cells lose their inhibition.
    Parham P
    Science; 2004 Aug; 305(5685):786-7. PubMed ID: 15297654
    [No Abstract]   [Full Text] [Related]  

  • 18. [Extracellular maturation of hepatitis C virus: a plasma cloak of invisibility].
    Chanut M; Granier C; Cosset FL; Denolly S
    Med Sci (Paris); 2019; 35(8-9):616-618. PubMed ID: 31532369
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterisation of a panel of monoclonal antibodies raised against recombinant HCV core protein.
    Ferns RB; Tuke PW; Sweenie CH
    J Med Virol; 1996 Nov; 50(3):221-9. PubMed ID: 8923286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Viral hepatitis type C: new facts and hypotheses].
    Juszczyk J
    Przegl Epidemiol; 2002; 56 Suppl 5():5-9. PubMed ID: 15553065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.